Tocilizumab in visual involvement of giant cell arteritis: a multicenter study of 471 patients

BACKGROUND: Visual involvement is the most feared complication of giant cell arteritis (GCA). Information on the efficacy of tocilizumab (TCZ) for this complication is scarce and controversial. OBJECTIVE: We assessed a wide series of GCA treated with TCZ, to evaluate its role in the prevention of ne...

Descripción completa

Detalles Bibliográficos
Autores principales: Loricera, Javier, Castañeda, Santos, Moriano, Clara, Narváez, Javier, Aldasoro, Vicente, Maiz, Olga, Melero, Rafael, Villa, Ignacio, Vela, Paloma, Romero-Yuste, Susana, Callejas, José L., de Miguel, Eugenio, Galíndez-Agirregoikoa, Eva, Sivera, Francisca, Fernández-López, Jesús C., Galisteo, Carles, Ferraz-Amaro, Iván, Sánchez-Martín, Julio, Sánchez-Bilbao, Lara, Calderón-Goercke, Mónica, Casado, Alfonso, Hernández, José L., González-Gay, Miguel A., Blanco, Ricardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310329/
https://www.ncbi.nlm.nih.gov/pubmed/35898567
http://dx.doi.org/10.1177/1759720X221113747

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310329/
https://www.ncbi.nlm.nih.gov/pubmed/35898567
http://dx.doi.org/10.1177/1759720X221113747

Ejemplares similares